Pafolacianine: Clinical Trials

17 trials of Pafolacianine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 6 recruiting, 1 not yet recruiting, 1 terminated. 4 Phase 1, 4 Phase 2, 3 Phase 3, 2 Early Phase 1, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 14Completed 1, Recruiting 1, Terminated 1, Withdrawn 1
Phase 24Completed 3, Recruiting 1
Phase 33Completed 2, Recruiting 1
Early Phase 12Recruiting 2
Phase 42Not yet recruiting 1, Recruiting 1
Not applicable1Completed 1

Follow this drug Literature Review of Pafolacianine trials Research Report on Pafolacianine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CYTALUX Dose Extension Study
CYTALUX (pafolacianine) injection - Cancer in the Lung, Ovarian Cancer
Phase 4Not yet recruitingOn Target Laboratories, LLC1062026-08-152026-08-18
CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer
CYTALUX™ (pafolacianine), 1788 4K Camera System with Advanced Imaging Modality - Endometrial Cancer, Near Infrared Fluorescence Imaging
Early Phase 1RecruitingAbramson Cancer Center at Penn Medicine102025-10-182025-12-12
Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
CYTALUX™ (pafolacianine) - Gastrointestinal Cancer, Gastric Cancer
Phase 4RecruitingCedars-Sinai Medical Center152025-09-052025-09-15
Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.
CYTALUX™ (pafolacianine) injection preoperatively - Esophageal Cancer, Gastrointestinal Cancers
Phase 2RecruitingJohn Waters502025-08-192026-06-05
An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors
Biospecimen Collection, Near Infrared Imaging, Pafolacianine Sodium - Childhood Malignant Solid Neoplasm, Childhood Malignant Thoracic Neoplasm
Phase 3RecruitingMayo Clinic202025-04-152026-04-01
PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis
Pafolacianine (CYTALUX) with intraoperative fluorescent near-infrared (NIR) imaging - Gastrointestinal Cancer, Peritoneal Carcinomatosis
Early Phase 1RecruitingUniversity of California, Irvine102024-11-132026-02-27
CYTALUX™for the Intraoperative Imaging of Prostate Cancer
Cytalux™ (pafolacianine) for fluorescent imaging, Image Guided Surgery - Prostate Cancer
Phase 2CompletedIndiana University92024-09-192026-06-01
Safety and Feasibility of Intraoperative Visualization With Cytalux in Children
Cytalux - Osteosarcoma, Pulmonary Metastasis
Phase 1RecruitingAnn & Robert H Lurie Children's Hospital of Chicago102024-04-082026-06-05
OTL38 Injection (OTL38) for Intra-Operative Imaging of Folate Receptor Positive Ovarian Cancer
OTL38, intraoperative imaging camera system - Ovarian Cancer
Phase 1WithdrawnAbramson Cancer Center at Penn Medicine2022-05-282022-06-27
ELUCIDATE: Enabling Lung Cancer Identification Using Folate Receptor Targeting
OTL38 for Injection, Near infrared camera imaging system - Lung Neoplasms, Lung Cancer
Phase 3CompletedOn Target Laboratories, LLC1122020-03-262023-03-23
OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer
OTL38, near infrared camera imaging system, laparotomy - Ovarian Cancer
Phase 3CompletedOn Target Laboratories, LLC1402018-01-262022-02-04
OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules
OTL38 for Injection, Near infrared camera imaging system, Endoscopic or Thoracic Surgery - Lung Neoplasms, Lung Cancer
Phase 2CompletedOn Target Laboratories, LLC1002017-05-042023-03-24
Solid Tumor Cancer Surgery With or Without Intraoperative Imaging: A Registry
OTL38, ICG - Bladder Cancer, Gastric Cancer
CompletedUniversity of Pennsylvania2912016-07-012021-06-18
Intraoperative Folate Targeted Fluorescence in Renal Cell Carcinoma
OTL38, Intraoperative fluorescence imaging system - Renal Cell Carcinoma
Not applicableCompletedChandru Sundaram142015-12-292020-02-25
Intraoperative Imaging of Pituitary Adenomas by OTL
OTL38 - Neoplasms, Pituitary Neoplasms
Phase 1TerminatedUniversity of Pennsylvania332015-10-012019-08-06
Intraoperative Imaging of Pulmonary Nodules by OTL38
OTL38 - Neoplasms
Phase 1CompletedUniversity of Pennsylvania2622015-05-012022-06-28
Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer
OTL38, Near infrared camera imaging system, Laparotomy - Ovarian Cancer
Phase 2CompletedOn Target Laboratories, LLC482014-12-012022-06-21

Conditions studied

Ovarian Neoplasms (4)  ·  Gastrointestinal Neoplasms (3)  ·  Lung Neoplasms (3)  ·  Esophageal Neoplasms (2)  ·  Neoplasms (2)  ·  Stomach Neoplasms (2)  ·  Appendiceal Neoplasms (1)  ·  Carcinoma, Renal Cell (1)  ·  Endometrial Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Osteosarcoma (1)  ·  Pelvic Neoplasms (1)  ·  Peritoneal Neoplasms (1)  ·  Pituitary Neoplasms (1)  ·  Prostatic Neoplasms (1)

Sponsors

On Target Laboratories, LLC (5)  ·  University of Pennsylvania (3)  ·  Abramson Cancer Center at Penn Medicine (2)  ·  Ann & Robert H Lurie Children's Hospital of Chicago (1)  ·  Cedars-Sinai Medical Center (1)  ·  Chandru Sundaram (1)  ·  Indiana University (1)  ·  John Waters (1)  ·  Mayo Clinic (1)  ·  University of California, Irvine (1)

Countries

United States (16)  ·  Netherlands (2)

Top investigators

Sunil Singhal, MD (3)  ·  Sunil Singhal (2)  ·  Chandru P. Sundaram, MD (1)  ·  Clinton Bahler, MD (1)  ·  Janos Tanyi, MD (1)  ·  John Waters, M.D. (1)  ·  Maheswari Senthil, MD (1)  ·  Miguel Burch, MD (1)  ·  Stephanie F. Polites, MD, MPH (1)  ·  Timothy Lautz, MD (1)

Results publications

PMID 36070540